Chronic myeloid leukemia: reaching for the cure

Curr Cancer Drug Targets. 2013 Sep;13(7):709-10. doi: 10.2174/15680096113139990091.

Authors

Alessio Nencioni¹, Michele Cea, Fabrizio Montecucco, Marco Gobbi, Franco Patrone

Affiliation

¹ Department of Internal Medicine University of Genoa V.le Benedetto XV 6, 16132 Genoa Italy. fpatrone@unige.it.

PMID: 23957630
DOI: 10.2174/15680096113139990091

No abstract available

Publication types

Editorial
Introductory Journal Article
Research Support, Non-U.S. Gov't

MeSH terms

Animals
Antineoplastic Agents / chemistry
Antineoplastic Agents / therapeutic use*
Drug Design*
Drug Resistance, Neoplasm
Fusion Proteins, bcr-abl / antagonists & inhibitors
Fusion Proteins, bcr-abl / genetics
Humans
Leukemia, Myelogenous, Chronic, BCR-ABL Positive / drug therapy*
Leukemia, Myelogenous, Chronic, BCR-ABL Positive / enzymology
Leukemia, Myelogenous, Chronic, BCR-ABL Positive / genetics
Leukemia, Myelogenous, Chronic, BCR-ABL Positive / pathology
Molecular Targeted Therapy*
Neoplastic Stem Cells / drug effects
Neoplastic Stem Cells / enzymology
Neoplastic Stem Cells / pathology
Protein Kinase Inhibitors / chemistry
Protein Kinase Inhibitors / therapeutic use*
Signal Transduction / drug effects
Treatment Outcome

Substances

Antineoplastic Agents
Protein Kinase Inhibitors
Fusion Proteins, bcr-abl